• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD, INC. CLEO® 90 INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD, INC. CLEO® 90 INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 21-7220-24
Device Problem Material Fragmentation (1261)
Patient Problems Hyperglycemia (1905); Device Embedded In Tissue or Plaque (3165)
Event Date 03/14/2017
Event Type  Injury  
Manufacturer Narrative
Customer has not yet returned the device to the manufacturer for device evaluation.When and if the device becomes available and is returned and evaluated the manufacturer will file a follow-up report detailing the results of the evaluation.It was reported that patient could not recall the exact date and the date reported was approximate.
 
Event Description
It was reported that during patient use of the cleo® 90 infusion set, the cannula detached from the infusion site and the cannula remained partially inserted in the patient's body.The patient stated that she believed that the waistband of their pants may have sheared the infusion site from the patient's body.The patient reported that they were able to remove the device cannula without issue.According to the reporter, the patient's blood glucose level rose to approximately 300 mg/dl at the time of the event; the patient did not test their ketone levels.The patient administered an insulin injection via a syringe to resolve their high blood glucose.Additionally, the patient reported that they replaced their infusion site and resumed insulin delivery from the infusion pump.No issues were observed when the device was initially opened and the patient stated that they received iv dressings to aid in securing future infusion sites.No permanent adverse effects to patient reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEO® 90 INFUSION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS MEDICAL ASD, INC.
6000 nathan lane north
minneapolis MN 55442
Manufacturer (Section G)
SMITHS HEALTHCARE MFG
s.a. de c.v. ave calidad no. 4
parque industrial internaciona
tijuana, b.c 22425
MX   22425
Manufacturer Contact
lisa perz
6000 nathan lane north
minneapolis, MN 55442
7633833074
MDR Report Key6487556
MDR Text Key72653563
Report Number3012307300-2017-00837
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10610586028335
UDI-Public10610586028335
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K042172
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,distributor
Reporter Occupation Other
Type of Report Initial
Report Date 04/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/28/2021
Device Catalogue Number21-7220-24
Device Lot Number76X132
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/22/2017
Initial Date FDA Received04/12/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/18/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
Patient Weight79
-
-